Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
KOL thinks Apellis Pharmaceuticals (APLS) issues with Syfovre 'likely solvable' - TD Cowen
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Apellis Pharmaceuticals (APLS) Still Has No FDA AdCom, Which is a Positive - Cowen
-
Cowen Reiterates Outperform Rating on Apellis Pharmaceuticals (APLS), 'We Remain Optimistic For Pegcetacoplan Approval'
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Pre-Open Stock Movers 09/10: (ISEE) (AFRM) (SANW) Higher; (APLS) (COOK) (SUMO) Lower (more...)
-
Iveric bio (ISEE): APLS Data As Good As Possible for Iveric, Buy Here - Analyst
-
After-Hours Stock Movers 09/09: (ISEE) (AFRM) (KPLT) Higher; (APLS) (COOK) (ZUMZ) Lower (more...)
-
Apellis Pharmaceuticals (APLS) PT Raised to $70 at Cowen After R&D Day
-
Apellis Pharmaceuticals (APLS) PT Raised to $60 at Cowen
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Apellis Pharmaceuticals to Present at the 40th Annual Cowen Health Care Conference
-
Apellis Pharmaceuticals to Present at the 40th Annual Cowen Health Care Conference
-
Pre-Open Stock Movers 01/07: (APLS) (TYME) (APA) Higher (CRNC) (ITCI) (ARE) Lower (more...)
-
Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Apellis Pharmaceuticals (APLS) Prices 6M Share Common Offering at $17/Sh
-
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Apellis Pharmaceuticals (APLS) to Offer $75M in Common Stock
-
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Apellis Pharmaceuticals to Present at the Cowen 39th Annual Health Care Conference
-
Apellis Pharmaceuticals to Present at the Cowen 39th Annual Health Care Conference
-
Cowen Starts Apellis Pharmaceuticals (APLS) at Outperform
-
Apellis Pharmaceuticals Announces Closing of Offering of Common Stock
-
Apellis Pharmaceuticals (APLS) Prices 5.5M Share Offering at $25.50/Sh
-
Apellis Pharmaceuticals Announces Pricing of Offering of Common Stock
-
Apellis Pharmaceuticals Announces Proposed Offering of Common Stock
-
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences

